The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Transform 30
Fucus Vesiculosus, Cysteinum, Nicotinamidum, Alpha-Lipoicum Acidum, Antimonium Crudum, Chromium Sulphuricum, Gambogia, Anacardium Orientale, Graphites · FUCUS VESICULOSUS 3 [hp_X]/mL; CYSTEINE 6 [hp_X]/mL; NIACINAMIDE 6 [hp_X]/mL; ALPHA LIPOIC ACID 12 [hp_X]/mL; ANTIMONY TRISULFIDE 12 [hp_X]/mL; CHROMIC SULFATE PENTADECAHYDRATE 12 [hp_X]/mL; GAMBOGE 12 [hp_X]/mL; SEMECARPUS ANACARDIUM JUICE 30 [hp_C]/mL; GRAPHITE 30 [hp_C]/mL · Liquid · Oral · H2 Nutrition
NDC 80814-0001-01 · 60 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Fucus Vesiculosus, Cysteinum, Nicotinamidum, Alpha-Lipoicum Acidum, Antimonium Crudum, Chromium Sulphuricum, Gambogia, Anacardium Orientale, Graphites (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| H2 Nutrition | FUCUS VESICULOSUS 3 [hp_X]/mL; CYSTEINE 6 [hp_X]/mL; NIACINAMIDE 6 [hp_X]/mL; ALPHA LIPOIC ACID 12 [hp_X]/mL; ANTIMONY TRISULFIDE 12 [hp_X]/mL; CHROMIC SULFATE PENTADECAHYDRATE 12 [hp_X]/mL; GAMBOGE 12 [hp_X]/mL; SEMECARPUS ANACARDIUM JUICE 30 [hp_C]/mL; GRAPHITE 30 [hp_C]/mL | Aug 26, 2026 | Sep 2, 2026 |
| Healthy Habits Management Company Inc. | FUCUS VESICULOSUS 3 [hp_X]/mL; CYSTEINE 6 [hp_X]/mL; NIACINAMIDE 6 [hp_X]/mL; ALPHA LIPOIC ACID 12 [hp_X]/mL; ANTIMONY TRISULFIDE 12 [hp_X]/mL; CHROMIC SULFATE PENTADECAHYDRATE 12 [hp_X]/mL; GAMBOGE 12 [hp_X]/mL; SEMECARPUS ANACARDIUM JUICE 30 [hp_C]/mL; GRAPHITE 30 [hp_C]/mL | Aug 26, 2026 | Sep 2, 2026 |
| H2 Nutrition | FUCUS VESICULOSUS 12 [hp_X]/mL; CYSTEINE 12 [hp_X]/mL; NIACINAMIDE 12 [hp_X]/mL; ALPHA LIPOIC ACID 6 [hp_X]/mL; ANTIMONY TRISULFIDE 3 [hp_X]/mL; CHROMIC SULFATE PENTADECAHYDRATE 12 [hp_X]/mL; GAMBOGE 30 [hp_C]/mL; SEMECARPUS ANACARDIUM JUICE 6 [hp_X]/mL; GRAPHITE 30 [hp_C]/mL | Jul 22, 2026 | Aug 19, 2026 |
| Healthy Habits Management Company Inc. | FUCUS VESICULOSUS 12 [hp_X]/mL; CYSTEINE 12 [hp_X]/mL; NIACINAMIDE 12 [hp_X]/mL; ALPHA LIPOIC ACID 6 [hp_X]/mL; ANTIMONY TRISULFIDE 3 [hp_X]/mL; CHROMIC SULFATE PENTADECAHYDRATE 12 [hp_X]/mL; GAMBOGE 30 [hp_C]/mL; SEMECARPUS ANACARDIUM JUICE 6 [hp_X]/mL; GRAPHITE 30 [hp_C]/mL | Jul 22, 2026 | Aug 19, 2026 |
| H2 Nutrition | ALPHA LIPOIC ACID 12 [hp_X]/mL; ANTIMONY TRISULFIDE 12 [hp_X]/mL; CHROMIC SULFATE PENTADECAHYDRATE 12 [hp_X]/mL; CYSTEINE 6 [hp_X]/mL; FUCUS VESICULOSUS 3 [hp_X]/mL; GAMBOGE 12 [hp_X]/mL; GRAPHITE 30 [hp_C]/mL; NIACINAMIDE 6 [hp_X]/mL; SEMECARPUS ANACARDIUM JUICE 30 [hp_C]/mL | Jul 15, 2026 | Jul 15, 2026 |
| Healthy Habits Management Company Inc. | ALPHA LIPOIC ACID 12 [hp_X]/mL; ANTIMONY TRISULFIDE 12 [hp_X]/mL; CHROMIC SULFATE PENTADECAHYDRATE 12 [hp_X]/mL; CYSTEINE 6 [hp_X]/mL; FUCUS VESICULOSUS 3 [hp_X]/mL; GAMBOGE 12 [hp_X]/mL; GRAPHITE 30 [hp_C]/mL; NIACINAMIDE 6 [hp_X]/mL; SEMECARPUS ANACARDIUM JUICE 30 [hp_C]/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Transform 30 — NDC 80814-0001-01," retrieved September 3, 2026, https://drugdashboards.com/drug/80814000101.
Free to cite with attribution — see how the data is put together.